相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Current Status of Psychedelics in Psychiatry
David Nutt et al.
JAMA PSYCHIATRY (2021)
Posttraumatic Stress Disorder After a Psychedelic Experience, a Case Report
Dafna Sara Rubin-Kahana et al.
JOURNAL OF ADDICTION MEDICINE (2021)
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder A Randomized Clinical Trial
Alan K. Davis et al.
JAMA PSYCHIATRY (2021)
Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers
Nadia R. P. W. Hutten et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial
Richard J. Zeifman et al.
PSYCHOPHARMACOLOGY (2021)
Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin
Oskar Hougaard Jefsen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2021)
LSD acutely impairs working memory, executive functions, and cognitive flexibility, but not risk-based decision-making
Thomas Pokorny et al.
PSYCHOLOGICAL MEDICINE (2020)
Ketamine for acute suicidal ideation. An emergency department intervention: A randomized, double-blind, placebo-controlled, proof-of-concept trial
Yoav Domany et al.
DEPRESSION AND ANXIETY (2020)
Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of D-lysergic acid diethylamide (LSD)
Adam L. Halberstadt et al.
NEUROPHARMACOLOGY (2020)
Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
Friederike Holze et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression
Meghan Hibicke et al.
ACS CHEMICAL NEUROSCIENCE (2020)
A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial
Elias Dakwar et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Maurizio Fava et al.
MOLECULAR PSYCHIATRY (2020)
GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions
Danielle M. Gerhard et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
LSD Overdoses: Three Case Reports
Mark Haden et al.
Journal of Studies on Alcohol and Drugs (2020)
A claustrum in reptiles and its role in slow-wave sleep
Hiroaki Norimoto et al.
NATURE (2020)
Emotions and brain function are altered up to one month after a single high dose of psilocybin
Frederick S. Barrett et al.
SCIENTIFIC REPORTS (2020)
AMPA receptor-mTORC1 signaling activation is required for neuroplastic effects of LY341495 in rat hippocampal neurons
Mi Kyoung Seo et al.
SCIENTIFIC REPORTS (2020)
Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models
Claire J. Foldi et al.
FRONTIERS IN NEUROSCIENCE (2020)
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey
Albert Garcia-Romeu et al.
FRONTIERS IN PSYCHIATRY (2020)
Dynamic coupling of whole-brain neuronal and neurotransmitter systems
Morten L. Kringelbach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Biased signaling by endogenous opioid peptides
Ivone Gomes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists
Alexander Gillis et al.
SCIENCE SIGNALING (2020)
Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients
Laura Basso et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention
Frederick S. Barrett et al.
NEUROIMAGE (2020)
Decreased directed functional connectivity in the psychedelic state
Lionel Barnett et al.
NEUROIMAGE (2020)
In vitro structure-activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor
Eline Pottie et al.
ARCHIVES OF TOXICOLOGY (2020)
Registered clinical trials investigating ketamine for psychiatric disorders
Bahareh Peyrovian et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2020)
Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca
Nicole Leite Galvao-Coelho et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Updating the dynamic framework of thought: Creativity and psychedelics
Manesh Girn et al.
NEUROIMAGE (2020)
Modulatory effects of ayahuasca on personality structure in a traditional framework
Nige Netzband et al.
PSYCHOPHARMACOLOGY (2020)
A single psychotomimetic dose of ketamine decreases thalamocortical spindles and delta oscillations in the sedated rat
A. Mahdavi et al.
SCHIZOPHRENIA RESEARCH (2020)
Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study
Nadia R. P. W. Hutten et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo
Jose A. Morales-Garcia et al.
TRANSLATIONAL PSYCHIATRY (2020)
Psychedelics as a novel approach to treating autoimmune conditions
Caitlin Thompson et al.
IMMUNOLOGY LETTERS (2020)
Can Psychedelic Drugs Attenuate Age-Related Changes in Cognition and Affect?
Jacob S. Aday et al.
JOURNAL OF COGNITIVE ENHANCEMENT (2020)
Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety
Alan K. Davis et al.
JOURNAL OF CONTEXTUAL BEHAVIORAL SCIENCE (2020)
The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study
Sameer Jauhar et al.
BIOLOGICAL PSYCHIATRY (2019)
Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects
Allison C. Nugent et al.
MOLECULAR PSYCHIATRY (2019)
Ketamine: A Paradigm Shift for Depression Research and Treatment
John H. Krystal et al.
NEURON (2019)
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
Martin K. Madsen et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Biased Receptor Signaling in Drug Discovery
Terry Kenakin
PHARMACOLOGICAL REVIEWS (2019)
A systematic study of microdosing psychedelics
Vince Polito et al.
PLOS ONE (2019)
Effective connectivity changes in LSD-induced altered states of consciousness in humans
Katrin H. Preller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
The hypothalamic-pituitary-adrenal axis in PTSD: Pathophysiology and treatment interventions
Boadie W. Dunlop et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Oxytocin-dependent reopening of a social reward learning critical period with MDMA
Romain Nardou et al.
NATURE (2019)
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
Michael C. Mithoefer et al.
PSYCHOPHARMACOLOGY (2019)
Conformational dynamics of the human serotonin transporter during substrate and drug binding
Ingvar R. Moller et al.
NATURE COMMUNICATIONS (2019)
Systematic Review of Gut Microbiota and Major Depression
Stephanie G. Cheung et al.
FRONTIERS IN PSYCHIATRY (2019)
A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
Ben Sessa et al.
FRONTIERS IN PSYCHIATRY (2019)
Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine
Xavier Lopez-Gil et al.
ACS CHEMICAL NEUROSCIENCE (2019)
A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial
Elias Dakwar et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers
Anya K. Bershad et al.
BIOLOGICAL PSYCHIATRY (2019)
Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
Leor Roseman et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research
Kim P. C. Kuypers et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
A Biased View of μ-Opioid Receptors?
Alexandra E. Conibear et al.
MOLECULAR PHARMACOLOGY (2019)
Central nervous system regeneration is driven by microglia necroptosis and repopulation
Amy F. Lloyd et al.
NATURE NEUROSCIENCE (2019)
Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose
Madeline M. Pantoni et al.
PHARMACOLOGICAL REVIEWS (2019)
Biosynthesis and Extracellular Concentrations of N, N-dimethyltryptamine (DMT) in Mammalian Brain
Jon G. Dean et al.
SCIENTIFIC REPORTS (2019)
(R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism
Yukio Ago et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2019)
Resting state functional connectivity and cognitive task-related activation of the human claustrum
Samuel R. Krimmel et al.
NEUROIMAGE (2019)
Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects
Lukasz Smigielski et al.
NEUROIMAGE (2019)
Beyond the Ligand: Extracellular and Transcellular G Protein-Coupled Receptor Complexes in Physiology and Pharmacology
Henry A. Dunn et al.
PHARMACOLOGICAL REVIEWS (2019)
Differential role of dose and environment in initiating and intensifying neurotoxicity caused by MDMA in rats
Ibrahim M. Shokry et al.
BMC PHARMACOLOGY & TOXICOLOGY (2019)
Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline
Allison A. Feduccia et al.
FRONTIERS IN PSYCHIATRY (2019)
The Effects of Low Doses of Lysergic Acid Diethylamide in Healthy Humans: Demystifying the Microdosing of Psychedelics
Katrin H. Preller
BIOLOGICAL PSYCHIATRY (2019)
5-HT2 receptor activation alleviates airway inflammation and structural remodeling in a chronic mouse asthma model
Thomas W. Flanagan et al.
LIFE SCIENCES (2019)
Activation of 5-HT2 Receptors Reduces Inflammation in Vascular Tissue and Cholesterol Levels in High-Fat Diet-Fed Apolipoprotein E Knockout Mice
Thomas W. Flanagan et al.
SCIENTIFIC REPORTS (2019)
No Influence of Dopamine System Gene Variations on Acute Effects of MDMA
Patrick Vizeli et al.
FRONTIERS IN PSYCHIATRY (2019)
Role of NMDA and AMPA glutamatergic receptors in the effects of social defeat on the rewarding properties of MDMA in mice
M. P. Garcia-Pardo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2019)
Effects of Acute and Repeated Treatment With Serotonin 5-HT2A Receptor Agonist Hallucinogens on Intracranial Self-Stimulation in Rats
Farhana Sakloth et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2019)
Serotonin2B receptors in the rat dorsal raphe nucleus exert a GABA-mediated tonic inhibitory control on serotonin neurons
Adeline Cathala et al.
EXPERIMENTAL NEUROLOGY (2019)
Neuroimaging of chronic MDMA (ecstasy) effects: A meta-analysis
Felix Mueller et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function
Matthew W. Johnson et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Acute effects of ayahuasca in a juvenile non-human primate model of depression
Flavia S. da Silva et al.
BRAZILIAN JOURNAL OF PSYCHIATRY (2019)
Distinct neural mechanisms for the prosocial and rewarding properties of MDMA
Boris D. Heifets et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions
Ricardo Jorge Dinis-Oliveira et al.
CURRENT MOLECULAR PHARMACOLOGY (2019)
Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents
Lindsay P. Cameron et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials
O. Kohler-Forsherg et al.
ACTA PSYCHIATRICA SCANDINAVICA (2019)
Disease burden and government spending on mental, neurological, and substance use disorders, and self-harm: cross-sectional, ecological study of health system response in the Americas
Daniel V. Vigo et al.
LANCET PUBLIC HEALTH (2019)
Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial
Raissa Nobrega de Almeida et al.
FRONTIERS IN PSYCHOLOGY (2019)
A rare case of physical dependence with psychedelic LSD - A case report
Tamonud Modak et al.
JOURNAL OF SUBSTANCE USE (2019)
No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA
Patrick Vizeli et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2018)
The thalamic reticular nucleus in schizophrenia and bipolar disorder: role of parvalbumin-expressing neuron networks and oxidative stress
P. Steullet et al.
MOLECULAR PSYCHIATRY (2018)
Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis
S. P. Leighton et al.
MOLECULAR PSYCHIATRY (2018)
LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm
Christopher Timmermann et al.
NEUROPHARMACOLOGY (2018)
Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression
Leor Roseman et al.
NEUROPHARMACOLOGY (2018)
Psychiatry & the psychedelic drugs. Past, present & future
James J. H. Rucker et al.
NEUROPHARMACOLOGY (2018)
Long-lasting subjective effects of LSD in normal subjects
Yasmin Schmid et al.
PSYCHOPHARMACOLOGY (2018)
Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects
Patrick C. Dolder et al.
PSYCHOPHARMACOLOGY (2018)
DARK Classics in Chemical Neuroscience: Phencyclidine (PCP)
Jeanette L. Bertron et al.
ACS CHEMICAL NEUROSCIENCE (2018)
A role for enhanced functions of sleep in psychedelic therapy?
Tom Froese et al.
ADAPTIVE BEHAVIOR (2018)
Role of AMPA glutamate receptors in the conditioned rewarding effects of MDMA in mice
M. P. Garcia-Pardo et al.
BEHAVIOURAL BRAIN RESEARCH (2018)
The novel mu-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception
Rob Hill et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Lysergic acid diethylamide causes photoreceptor cell damage through inducing inflammatory response and oxidative stress
Qi-Di Hu et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2018)
Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression
C. Sophia Albott et al.
JOURNAL OF CLINICAL PSYCHIATRY (2018)
Ketamine Anesthesia Does Not Improve Depression Scores in Electroconvulsive Therapy: A Randomized Clinical Trial
Charles William Carspecken et al.
JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY (2018)
Human Metabolome Changes after a Single Dose of 3,4-Methylenedioxymethamphetamine (MDMA) with Special Focus on Steroid Metabolism and Inflammation Processes
Martina I. Boxler et al.
JOURNAL OF PROTEOME RESEARCH (2018)
Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression
Naomi R. Wray et al.
NATURE GENETICS (2018)
Ergot Alkaloids and their Hallucinogenic Potential in Morning Glories
Ulrike Steiner et al.
PLANTA MEDICA (2018)
Oxytocin receptor gene variations and socio-emotional effects of MDMA: A pooled analysis of controlled studies in healthy subjects
Patrick Vizeli et al.
PLOS ONE (2018)
Changes in the serum levels of inflammatory cytokines in antidepressant drug-naive patients with major depression
Wei Zou et al.
PLOS ONE (2018)
TRPV1 channels and the progesterone receptor Sig-1R interact to regulate pain
Miguel Ortiz-Renteria et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?
Allison A. Feduccia et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Epigenetics applied to psychiatry: Clinical opportunities and future challenges
Lara Kular et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2018)
Anterior Cingulate Cortex Input to the Claustrum Is Required for Top-Down Action Control
Michael G. White et al.
CELL REPORTS (2018)
Psychedelics Promote Structural and Functional Neural Plasticity
Calvin Ly et al.
CELL REPORTS (2018)
Hypothesis: The Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process
Antonio Inserra
FRONTIERS IN PHARMACOLOGY (2018)
Four Weekly Ayahuasca Sessions Lead to Increases in Acceptance Capacities: A Comparison Study With a Standard 8-Week Mindfulness Training Program
Joaquim Soler et al.
FRONTIERS IN PHARMACOLOGY (2018)
Altered network hub connectivity after acute LSD administration
Felix Mueller et al.
NEUROIMAGE-CLINICAL (2018)
Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls
Ana C. de Menezes Galvao et al.
FRONTIERS IN PSYCHIATRY (2018)
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
Nolan R. Williams et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Ketamine augmentation for major depressive disorder and suicidal ideation: Preliminary experience in an inpatient psychiatry setting
Mark Sinyor et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Ketamine blocks bursting in the lateral habenula to rapidly relieve depression
Yan Yang et al.
NATURE (2018)
Inflammaging: a new immune-metabolic viewpoint for age-related diseases
Claudio Franceschi et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Mechanisms of signalling and biased agonism in G protein-coupled receptors
Denise Wootten et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition
Frederick S. Barrett et al.
PSYCHOPHARMACOLOGY (2018)
Predicting Responses to Psychedelics: A Prospective Study
Eline C. H. M. Haijen et al.
FRONTIERS IN PHARMACOLOGY (2018)
Hallucinogen persisting perception disorder: A literature review and three case reports
Valentin Yurievich Skryabin et al.
JOURNAL OF ADDICTIVE DISEASES (2018)
The trip of a lifetime: hallucinogen persisting perceptual disorder
Lauren Anderson et al.
AUSTRALASIAN PSYCHIATRY (2018)
Psychedelics as anti-inflammatory agents
Thomas W. Flanagan et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2018)
Development and Validation of the Dissociative Symptoms Scale
Eve B. Carlson et al.
ASSESSMENT (2018)
Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation
Cristina Cusin et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2017)
Increased functional connectivity between the default mode and salience networks in unmedicated adults with obsessive-compulsive disorder
Jonathan Posner et al.
HUMAN BRAIN MAPPING (2017)
Organization of the Connections Between Claustrum and Cortex in the Mouse
Quanxin Wang et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2017)
Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: a randomized, crossover trial
E. Dakwar et al.
MOLECULAR PSYCHIATRY (2017)
Dopamine System Dysregulation in Major Depressive Disorders
Pauline Belujon et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)
Sex-Dependent Effects of Stress on Immobility Behavior and VTA Dopamine Neuron Activity: Modulation by Ketamine
Millie Rincon-Cortes et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)
Thalamocortical connectivity in major depressive disorder
Elliot C. Brown et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism
Lily R. Aleksandrova et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2017)
Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness
Matthias Forstmann et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Depletion of adult neurogenesis exacerbates cognitive deficits in Alzheimer's disease by compromising hippocampal inhibition
Carolyn Hollands et al.
MOLECULAR NEURODEGENERATION (2017)
Inflammation, metaflammation and immunometabolic disorders
Gokhan S. Hotamisligil
NATURE (2017)
Targeting glutamate signalling in depression: progress and prospects
James W. Murrough et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
A Brainstem-Spinal Cord Inhibitory Circuit for Mechanical Pain Modulation by GABA and Enkephalins
Amaury Francois et al.
NEURON (2017)
Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice
T. H. Pham et al.
NEUROPHARMACOLOGY (2017)
Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism
Karen J. Parker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis
Jelle V. Zorn et al.
PSYCHONEUROENDOCRINOLOGY (2017)
Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation
Rainer Kraehenmann et al.
PSYCHOPHARMACOLOGY (2017)
Reduced sleep spindle activity point to a TRN-MD thalamus-PFC circuit dysfunction in schizophrenia
Fabio Ferrarelli et al.
SCHIZOPHRENIA RESEARCH (2017)
Aberrant Network Activity in Schizophrenia
Mark J. Hunt et al.
TRENDS IN NEUROSCIENCES (2017)
Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease
Dasiel O. Borroto-Escuela et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission
Danielle O. Sambo et al.
NATURE COMMUNICATIONS (2017)
Loss of mTORC1 signalling impairs β-cell homeostasis and insulin processing
Manuel Blandino-Rosano et al.
NATURE COMMUNICATIONS (2017)
Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting
Elena Argento et al.
BMJ OPEN (2017)
The role of 5-HT receptors in depression
Christine N. Yohn et al.
MOLECULAR BRAIN (2017)
Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects
F. Mueller et al.
TRANSLATIONAL PSYCHIATRY (2017)
A Single Dose of LSD Does Not Alter Gene Expression of the Serotonin 2A Receptor Gene (HTR2A) or Early Growth Response Genes (EGR1-3) in Healthy Subjects
Patrick C. Dolder et al.
FRONTIERS IN PHARMACOLOGY (2017)
The Endless Trip among the nPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review
Laura Orsolini et al.
FRONTIERS IN PSYCHIATRY (2017)
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
Robin L. Carhart-Harris et al.
SCIENTIFIC REPORTS (2017)
Increased pro-inflammatory milieu in combat related PTSD - A new cohort replication study
Daniel Lindqvist et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
A Physician's Attempt to Self-Medicate Bipolar Depression with N,N-Dimethyltryptamine (DMT)
Tanida Brown et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2017)
Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations
F. Mueller et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects
Patrick C. Dolder et al.
CLINICAL PHARMACOKINETICS (2017)
Developing Guidelines and Competencies for the Training of Psychedelic Therapists
Janis Phelps
JOURNAL OF HUMANISTIC PSYCHOLOGY (2017)
Male and Female Mice Lacking Neuroligin-3 Modify the Behavior of Their Wild-Type Littermates
Shireene Kalbassi et al.
ENEURO (2017)
How do antidepressants work? New perspectives for refining future treatment approaches
Catherine J. Harmer et al.
LANCET PSYCHIATRY (2017)
The Role of Early Growth Response 1 (EGR1) in Brain Plasticity and Neuropsychiatric Disorders
Florian Duclot et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2017)
Crystal Structure of an LSD-Bound Human Serotonin Receptor
Daniel Wacker et al.
CELL (2017)
Phosphoproteomics in the Age of Rapid and Deep Proteome Profiling
Nicholas M. Riley et al.
ANALYTICAL CHEMISTRY (2016)
Default mode network dissociation in depressive and anxiety states
Joana Fernandes Coutinho et al.
BRAIN IMAGING AND BEHAVIOR (2016)
Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans
Patrick C. Dolder et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Modulation of GABA release from the thalamic reticular nucleus by cocaine and caffeine: role of serotonin receptors
Belen Goitia et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α
D. Baumeister et al.
MOLECULAR PSYCHIATRY (2016)
Hypothalamic feedforward inhibition of thalamocortical network controls arousal and consciousness
Carolina Gutierrez Herrera et al.
NATURE NEUROSCIENCE (2016)
Withdrawal from Acute Amphetamine Induces an Amygdala-Driven Attenuation of Dopamine Neuron Activity: Reversal by Ketamine
Pauline Belujon et al.
NEUROPSYCHOPHARMACOLOGY (2016)
The Genetics of Stress-Related Disorders: PTSD, Depression, and Anxiety Disorders
Jordan W. Smoller
NEUROPSYCHOPHARMACOLOGY (2016)
Hypothetical orchestrated cooperation between dopaminergic and kinin receptors for the regulation of common functions
Ibeth Guevara-Lora et al.
ACTA BIOCHIMICA POLONICA (2016)
Sex Differences in Effects of Ketamine on Behavior, Spine Density, and Synaptic Proteins in Socially Isolated Rats
Ambalika Sarkar et al.
BIOLOGICAL PSYCHIATRY (2016)
Fluoxetine treatment affects the inflammatory response and microglial function according to the quality of the living environment
Silvia Alboni et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Sex differences in the locus coeruleus-norepinephrine system and its regulation by stress
Debra A. Bangasser et al.
BRAIN RESEARCH (2016)
Ketamine abuse potential and use disorder
Yu Liu et al.
BRAIN RESEARCH BULLETIN (2016)
Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution
Enzo Tagliazucchi et al.
CURRENT BIOLOGY (2016)
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
Anna Rickli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
LSD-Induced Entropic Brain Activity Predicts Subsequent Personality Change
A. V. Lebedev et al.
HUMAN BRAIN MAPPING (2016)
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression A SPECT Study
Rafael Faria Sanches et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
Dopamine D2 and serotonin 5-HT1A receptor interaction in the context of the effects of antipsychotics - in vitro studies
Sylwia Lukasiewicz et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects
P. Strajhar et al.
JOURNAL OF NEUROENDOCRINOLOGY (2016)
Ketamine: NMDA Receptors and Beyond
Charles F. Zorumski et al.
JOURNAL OF NEUROSCIENCE (2016)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways
G. B. Rogers et al.
MOLECULAR PSYCHIATRY (2016)
Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition
M-L Wong et al.
MOLECULAR PSYCHIATRY (2016)
Crystal structure of the human σ1 receptor
Hayden R. Schmidt et al.
NATURE (2016)
Thalamic reticular impairment underlies attention deficit in Ptchd1Y/- mice
Michael F. Wells et al.
NATURE (2016)
Structure-based discovery of opioid analgesics with reduced side effects
Aashish Manglik et al.
NATURE (2016)
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Ronald S. Duman et al.
NATURE MEDICINE (2016)
Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression
Anthony A. Grace
NATURE REVIEWS NEUROSCIENCE (2016)
Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?
Attila Szabo et al.
NEURAL REGENERATION RESEARCH (2016)
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Patrick C. Dolder et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Epigenetic Basis of Mental Illness
Eric J. Nestler et al.
NEUROSCIENTIST (2016)
Antidepressant-like effects of ascorbic acid and ketamine involve modulation of GABA(A) and GABA(B) receptors
Priscila B. Rosa et al.
PHARMACOLOGICAL REPORTS (2016)
The hallucinogen D-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors
Danilo De Gregorio et al.
PHARMACOLOGICAL RESEARCH (2016)
Neural correlates of the LSD experience revealed by multimodal neuroimaging
Robin L. Carhart-Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults
Alicia L. Danforth et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine
Chun Yang et al.
PSYCHIATRY RESEARCH (2016)
Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking
K. P. C. Kuypers et al.
PSYCHOPHARMACOLOGY (2016)
Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia
Jose L. Moreno et al.
SCIENCE SIGNALING (2016)
Hippocampal neurogenesis enhancers promote forgetting of remote fear memory after hippocampal reactivation by retrieval
Rie Ishikawa et al.
ELIFE (2016)
Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia
Jose L. Moreno et al.
SCIENCE SIGNALING (2016)
The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization
Ede Frecska et al.
FRONTIERS IN PHARMACOLOGY (2016)
Psychedelics Recruit Multiple Cellular Types and Produce Complex Transcriptional Responses Within the Brain
David A. Martin et al.
EBIOMEDICINE (2016)
Ketamine Administration During the Second Postnatal Week Alters Synaptic Properties of Fast-Spiking Interneurons in the Medial Prefrontal Cortex of Adult Mice
Vivek Jeevakumar et al.
CEREBRAL CORTEX (2016)
Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters
Adem Can et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Cortico-Striatal-Thalamic Loop Circuits of the Salience Network: A Central Pathway in Psychiatric Disease and Treatment
Sarah K. Peters et al.
FRONTIERS IN SYSTEMS NEUROSCIENCE (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
Serotonin 5-HT2 receptor activation prevents allergic asthma in a mouse model
Felix Nau et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
Chadi G. Abdallah et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Oxytocin Reduces Amygdala Activity, Increases Social Interactions, and Reduces Anxiety-Like Behavior Irrespective of NMDAR Antagonism
Rosanna Sobota et al.
BEHAVIORAL NEUROSCIENCE (2015)
Involvement of NMDA glutamate receptors in the acquisition and reinstatement of the conditioned place preference induced by MDMA
Maria P. Garcia-Pardo et al.
BEHAVIOURAL PHARMACOLOGY (2015)
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Yasmin Schmid et al.
BIOLOGICAL PSYCHIATRY (2015)
Homeostasis, Inflammation, and Disease Susceptibility
Maya E. Kotas et al.
CELL (2015)
N,N-Dimethyltryptamine-Induced Psychosis
Neil E. Paterson et al.
CLINICAL NEUROPHARMACOLOGY (2015)
Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans
Jose Carlos Bouso et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Inflammation and clinical response to treatment in depression: A meta-analysis
R. Strawbridge et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin
Alexander V. Lebedev et al.
HUMAN BRAIN MAPPING (2015)
Ketamine-Induced Modulation of the Thalamo-Cortical Network in Healthy Volunteers As a Model for Schizophrenia
Anna Hoeflich et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Stress Induces the Danger-Associated Molecular Pattern HMGB-1 in the Hippocampus of Male Sprague Dawley Rats: A Priming Stimulus of Microglia and the NLRP3 Inflammasome
Michael D. Weber et al.
JOURNAL OF NEUROSCIENCE (2015)
Motor Cortex Layer V Pyramidal Neurons Exhibit Dendritic Regression, Spine Loss, and Increased Synaptic Excitation in the Presymptomatic hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
Matthew J. Fogarty et al.
JOURNAL OF NEUROSCIENCE (2015)
Role of sigma-1 receptors in neurodegenerative diseases
Linda Nguyen et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)
Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: An in vivo electrophysiological study on monoaminergic and glutamatergic neurons
Kareem S. El Iskandrani et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population
Peter S. Hendricks et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Psychedelics not linked to mental health problems or suicidal behavior: A population study
Pal-Orjan Johansen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Michael P. Bogenschutz et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Theo Vos et al.
LANCET (2015)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder
Veronica Reinhart et al.
NEUROBIOLOGY OF DISEASE (2015)
Paradoxical sleep: A vigilance state to gate long-term brain plasticity?
Pascal Ravassard et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2015)
Receptor interaction profiles of novel N-2-methoxybenzyl (NSOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)
Anna Rickli et al.
NEUROPHARMACOLOGY (2015)
Sigma-1 receptor mediates cocaine-induced transcriptional regulation by recruiting chromatin-remodeling factors at the nuclear envelope
Shang-Yi A. Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
LSD enhances the emotional response to music
M. Kaelen et al.
PSYCHOPHARMACOLOGY (2015)
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
Flavia de L. Osorio et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2015)
Ketamine Dysregulates the Amplitude and Connectivity of High-Frequency Oscillations in Cortical-Subcortical Networks in Humans: Evidence From Resting-State Magnetoencephalography-Recordings
Davide Rivolta et al.
SCHIZOPHRENIA BULLETIN (2015)
The role of serotonin and its receptors in activation of immune responses and inflammation
M. S. Shajib et al.
ACTA PHYSIOLOGICA (2015)
The DTI Connectivity of the Human Claustrum
Carinna M. Torgerson et al.
HUMAN BRAIN MAPPING (2015)
LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
Peter Gasser et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network
Fernanda Palhano-Fontes et al.
PLOS ONE (2015)
LSD enhances suggestibility in healthy volunteers
R. L. Carhart-Harris et al.
PSYCHOPHARMACOLOGY (2015)
The role of 5-HT2A, 5-HT2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice
Theresa M. Carbonaro et al.
PSYCHOPHARMACOLOGY (2015)
Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT2A receptors, in mice
William E. Fantegrossi et al.
PSYCHOPHARMACOLOGY (2015)
Switch to mania after ayahuasca consumption in a man with bipolar disorder: a case report
Alejandro G. Szmulewicz et al.
INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS (2015)
Chiral Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine and its Phase I and II Metabolites following Controlled Administration to Humans
Andrea E. Steuer et al.
DRUG METABOLISM AND DISPOSITION (2015)
Synthesis and Structure-Activity Relationships of N-Benzyl Phenethylamines as 5-HT2A/2c Agonists
Martin Hansen et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes
Dasiel O. Borroto-Escuela et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
The Effects of Subanesthetic Ketamine Infusions on Motivation to Quit and Cue-Induced Craving in Cocaine-Dependent Research Volunteers
Elias Dakwar et al.
BIOLOGICAL PSYCHIATRY (2014)
Restoring Mood Balance in Depression: Ketamine Reverses Deficit in Dopamine-Dependent Synaptic Plasticity
Pauline Belujon et al.
BIOLOGICAL PSYCHIATRY (2014)
Phencyclidine Inhibits the Activity of Thalamic Reticular Gamma-Aminobutyric Acidergic Neurons in Rat Brain
Eva Troyano-Rodriguez et al.
BIOLOGICAL PSYCHIATRY (2014)
A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
Kyle A. B. Lapidus et al.
BIOLOGICAL PSYCHIATRY (2014)
BDNF serum levels in subjects developing or not post-traumatic stress disorder after trauma exposure
Francesco Angelucci et al.
BRAIN AND COGNITION (2014)
NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder
Elisabet Alcocer-Gomez et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Default mode network subsystem alterations in obsessive-compulsive disorder
Jan C. Beucke et al.
BRITISH JOURNAL OF PSYCHIATRY (2014)
Serotonergic Modulation of Intrinsic Functional Connectivity
Alexander Schaefer et al.
CURRENT BIOLOGY (2014)
The default mode network and social understanding of others: what do brain connectivity studies tell us
Wanqing Li et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2014)
The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers
Leor Roseman et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2014)
Full recovery after severe serotonin syndrome, severe rhabdomyolysis, multi-organ failure and disseminated intravascular coagulopathy from MDMA
O. Davies et al.
HEART & LUNG (2014)
Reduced Functional Connectivity Within the Limbic Cortico-Striato-Thalamo-Cortical Loop in Unmedicated Adults With Obsessive-Compulsive Disorder
Jonathan Posner et al.
HUMAN BRAIN MAPPING (2014)
MDMA is certainly damaging after 25 years of empirical research: a reply and refutation of Doblin et al. (2014)
Andrew C. Parrott
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2014)
A reconsideration and response to Parrott AC (2013) Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research
Rick Doblin et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2014)
Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination
Cedric M. Hysek et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs
Maurizio S. Riga et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
A Direct Interaction between the Sigma-1 Receptor and the hERG Voltage-gated K+ Channel Revealed by Atomic Force Microscopy and Homogeneous Time-resolved Fluorescence (HTRF®)
Dilshan Balasuriya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Effect of Baseline Anxious Depression on Initial and Sustained Antidepressant Response to Ketamine
Dawn F. Ionescu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
Peter Gasser et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2014)
Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling
Tobias Buchborn et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
Matthew W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
A Functional Selectivity Mechanism at the Serotonin-2A GPCR Involves Ligand-Dependent Conformations of Intracellular Loop 2
Jose Manuel Perez-Aguilar et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Quantitative Phosphoproteomics Unravels Biased Phosphorylation of Serotonin 2A Receptor at Ser280 by Hallucinogenic versus Nonhallucinogenic Agonists
Samah Karaki et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)
M. L. Molendijk et al.
MOLECULAR PSYCHIATRY (2014)
PTSD risk is associated with BDNF Val66Met and BDNF overexpression
L. Zhang et al.
MOLECULAR PSYCHIATRY (2014)
Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia
David A. Martin et al.
NEUROPHARMACOLOGY (2014)
Disrupting posterior cingulate connectivity disconnects consciousness from the external environment
Guillaume Herbet et al.
NEUROPSYCHOLOGIA (2014)
Heteromeric Dopamine Receptor Signaling Complexes: Emerging Neurobiology and Disease Relevance
Melissa L. Perreault et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Effects of MDMA and Intranasal Oxytocin on Social and Emotional Processing
Matthew G. Kirkpatrick et al.
NEUROPSYCHOPHARMACOLOGY (2014)
SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models
Yoko Ono et al.
NEUROSCIENCE LETTERS (2014)
Psychedelic N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells
Attila Szabo et al.
PLOS ONE (2014)
Intranasal oxytocin as strategy for medication-enhanced psychotherapy of PTSD: Salience processing and fear inhibition processes
Saskia B. J. Koch et al.
PSYCHONEUROENDOCRINOLOGY (2014)
Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans
Matthew G. Kirkpatrick et al.
PSYCHONEUROENDOCRINOLOGY (2014)
Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes
Bruce E. Blough et al.
PSYCHOPHARMACOLOGY (2014)
Biased ligands at G-protein-coupled receptors: promise and progress
Jonathan D. Violin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Parkinson's disease: animal models and dopaminergic cell vulnerability
Javier Blesa et al.
FRONTIERS IN NEUROANATOMY (2014)
Corticothalamic phase synchrony and cross-frequency coupling predict human memory formation
Catherine M. Sweeney-Reed et al.
ELIFE (2014)
Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder A Randomized Clinical Trial
Adriana Feder et al.
JAMA PSYCHIATRY (2014)
The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
Kenji Hashimoto
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2014)
A Dialogue between the Immune System and Brain, Spoken in the Language of Serotonin
Nicole L. Baganz et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
James W. Murrough et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Recreational use of naturally occurring dimethyltryptamine - contributing to psychosis?
Johanna M. Warren et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2013)
Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
James W. Murrough et al.
BIOLOGICAL PSYCHIATRY (2013)
Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies
Amirhossein Modabbernia et al.
BIOLOGICAL PSYCHIATRY (2013)
Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells
Hannah Gola et al.
BMC PSYCHIATRY (2013)
Dynamic Interaction between Sigma-1 Receptor and Kv1.2 Shapes Neuronal and Behavioral Responses to Cocaine
Said Kourrich et al.
CELL (2013)
Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells
Melissa Cavalheiro Tourino et al.
CELL BIOCHEMISTRY AND FUNCTION (2013)
Sleep, Plasticity and Memory from Molecules to Whole-Brain Networks
Ted Abel et al.
CURRENT BIOLOGY (2013)
Effects of a short-course MDMA binge on dopamine transporter binding and on levels of dopamine and its metabolites in adult male rats
Dominik K. Biezonski et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Human psychobiology of MDMA or Ecstasy': an overview of 25years of empirical research
Andrew C. Parrott
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2013)
α1-Adrenergic Receptors Contribute to the Acute Effects of 3,4-Methylenedioxymethamphetamine in Humans
Cedric M. Hysek et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity
Ede Frecska et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
MDMA Increases Glutamate Release and Reduces Parvalbumin-Positive GABAergic Cells in the Dorsal Hippocampus of the Rat: Role of Cyclooxygenase
John H. Anneken et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Broadband Cortical Desynchronization Underlies the Human Psychedelic State
Suresh D. Muthukumaraswamy et al.
JOURNAL OF NEUROSCIENCE (2013)
Chronic Stress Induces a Selective Decrease in AMPA Receptor-Mediated Synaptic Excitation at Hippocampal Temporoammonic-CA1 Synapses
Angy J. Kallarackal et al.
JOURNAL OF NEUROSCIENCE (2013)
Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations
Michael Kometer et al.
JOURNAL OF NEUROSCIENCE (2013)
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study
Michael C. Mithoefer et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
Harvey A. Whiteford et al.
LANCET (2013)
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis
Jordan W. Smoller et al.
LANCET (2013)
Increased vulnerability of the brain norepinephrine system of females to corticotropin-releasing factor overexpression
D. A. Bangasser et al.
MOLECULAR PSYCHIATRY (2013)
mTOR complexes in neurodevelopmental and neuropsychiatric disorders
Mauro Costa-Mattioli et al.
NATURE NEUROSCIENCE (2013)
OPINION Signalling bias in new drug discovery: detection, quantification and therapeutic impact
Terry Kenakin et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
The two faces of the pharmacological interaction of mGlu2 and 5-HT2A - Relevance of receptor heterocomplexes and interaction through functional brain pathways
Hannah K. Delille et al.
NEUROPHARMACOLOGY (2013)
HPA-AXIS HORMONE MODULATION OF STRESS RESPONSE CIRCUITRY ACTIVITY IN WOMEN WITH REMITTED MAJOR DEPRESSION
L. M. Holsen et al.
NEUROSCIENCE (2013)
Chronic treatment with LY341495 decreases 5-HT2A receptor binding and hallucinogenic effects of LSD in mice
Jose L. Moreno et al.
NEUROSCIENCE LETTERS (2013)
The effects of ketamine on dexmedetomidine-induced electrophysiologic changes in children
Danton Char et al.
PEDIATRIC ANESTHESIA (2013)
Positive Outcomes Influence the Rate and Time to Publication, but Not the Impact Factor of Publications of Clinical Trial Results
Pilar Sune et al.
PLOS ONE (2013)
Stimulation of the Sigma-1 Receptor by DHEA Enhances Synaptic Efficacy and Neurogenesis in the Hippocampal Dentate Gyrus of Olfactory Bulbectomized Mice
Shigeki Moriguchi et al.
PLOS ONE (2013)
Serotonin 5-HT2A Receptor Activation Blocks TNF-α Mediated Inflammation In Vivo
Felix Nau et al.
PLOS ONE (2013)
BDNF Val66Met and DRD2 Taq1A polymorphisms interact to influence PTSD symptom severity: A preliminary investigation in a South African population
Sian M. J. Hemmings et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Monoamine neurocircuitry in depression and strategies for new treatments
Michel Hamon et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Oxytocinergic manipulations in corticolimbic circuit differentially affect fear acquisition and extinction
Nisrine Lahoud et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Oxytocin and psychotherapy: A pilot study of its physiological, behavioral and subjective effects in males with depression
Kai MacDonald et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism
Valentina Gigliucci et al.
PSYCHOPHARMACOLOGY (2013)
Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users
Jose Carlos Bouso et al.
PSYCHOPHARMACOLOGY (2013)
Subanaesthetic Ketamine Treatment Alters Prefrontal Cortex Connectivity With Thalamus and Ascending Subcortical Systems
Neil Dawson et al.
SCHIZOPHRENIA BULLETIN (2013)
Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis
Robin L. Carhart-Harris et al.
SCHIZOPHRENIA BULLETIN (2013)
Structural Features for Functional Selectivity at Serotonin Receptors
Daniel Wacker et al.
SCIENCE (2013)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects
Alkomiet Hasan et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2013)
The Role of Oxytocin in Psychiatric Disorders: A Review of Biological and Therapeutic Research Findings
David M. Cochran et al.
HARVARD REVIEW OF PSYCHIATRY (2013)
Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning
Briony J. Catlow et al.
EXPERIMENTAL BRAIN RESEARCH (2013)
A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with Morphines
Scott M. DeWire et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Functional Selectivity in Serotonin Receptor 2A (5-HT2A) Endocytosis, Recycling, and Phosphorylation
Ishier Raote et al.
MOLECULAR PHARMACOLOGY (2013)
Regulation of mu-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and Tolerance
John T. Williams et al.
PHARMACOLOGICAL REVIEWS (2013)
2C or Not 2C: Phenethylamine Designer Drug Review
Be Vang Dean et al.
JOURNAL OF MEDICAL TOXICOLOGY (2013)
Molecular Mechanism of beta-Arrestin-Biased Agonism at Seven-Transmembrane Receptors
Eric Reiter et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors
Michael Kometer et al.
BIOLOGICAL PSYCHIATRY (2012)
Synaptic Potentiation Is Critical for Rapid Antidepressant Response to Ketamine in Treatment-Resistant Major Depression
Brian R. Cornwell et al.
BIOLOGICAL PSYCHIATRY (2012)
A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia
Ross J. Tynan et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
Pharmacogenomics Knowledge for Personalized Medicine
M. Whirl-Carrillo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers
Matthew W. Johnson et al.
DRUG AND ALCOHOL DEPENDENCE (2012)
The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements
Arindam Pal et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo
Matthew J. Robson et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States
Ronald C. Kessler et al.
INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH (2012)
The Nuclear Envelope Protein Emerin Binds Directly to Histone Deacetylase 3 (HDAC3) and Activates HDAC3 Activity
Justin Demmerle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking
Ute Renner et al.
JOURNAL OF CELL SCIENCE (2012)
The Psychopharmacology of Aggressive Behavior: A Translational Approach Part 2: Clinical Studies Using Atypical Antipsychotics, Anticonvulsants, and Lithium
Stefano Comai et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
Imran B. Chaudhry et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
A Case of Serotonin Syndrome with Antidepressant Treatment and Concomitant use of The Herbal Remedy (Peganum Harmala)
Bahadir Bakim et al.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Theo Vos et al.
LANCET (2012)
BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity
J. J. Rakofsky et al.
MOLECULAR PSYCHIATRY (2012)
Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine- induced psychopathology
J. M. Stone et al.
MOLECULAR PSYCHIATRY (2012)
Synergistic tonic and phasic activity of the locus coeruleus norepinephrine (LC-NE) arousal system is required for optimal attentional performance
Fleur M. Howells et al.
METABOLIC BRAIN DISEASE (2012)
Memory signals from the thalamus: Early thalamocortical phase synchronization entrains gamma oscillations during long-term memory retrieval
Tobias Staudigl et al.
NEUROPSYCHOLOGIA (2012)
Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers
Boris B. Quednow et al.
NEUROPSYCHOPHARMACOLOGY (2012)
TESTS AND MODELS OF NOCICEPTION AND PAIN IN RODENTS
M. Barrot
NEUROSCIENCE (2012)
ANTIDEPRESSANT-LIKE EFFECTS OF LOW KETAMINE DOSE IS ASSOCIATED WITH INCREASED HIPPOCAMPAL AMPA/NMDA RECEPTOR DENSITY RATIO IN FEMALE WISTAR-KYOTO RATS
Y. Tizabi et al.
NEUROSCIENCE (2012)
Into the Eye of the Cytokine Storm
Jennifer R. Tisoncik et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2012)
The Brain's Default Network and Its Adaptive Role in Internal Mentation
Jessica R. Andrews-Hanna
NEUROSCIENTIST (2012)
Prediction of Psilocybin Response in Healthy Volunteers
Erich Studerus et al.
PLOS ONE (2012)
Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study
Jose Carlos Bouso et al.
PLOS ONE (2012)
Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy''): The Influence of Gender and Genetics (CYP2D6, COMT, 5-HTT)
Ricardo Pardo-Lozano et al.
PLOS ONE (2012)
Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD)
Emmanuelle A. D. Schindler et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Mental time travel and default-mode network functional connectivity in the developing brain
Ylva Ostby et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Robin L. Carhart-Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Minocycline as adjunctive therapy for patients with unipolar psychotic depression: An open-label study
Tsuyoshi Miyaoka et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Characterization of serotonin neurotransmission in knockout mice: implications for major depression
Sergio Dominguez-Lopez et al.
REVIEWS IN THE NEUROSCIENCES (2012)
Pre-treatment with the mGlu2/3 receptor agonist LY379268 attenuates DOI-induced impulsive responding and regional c-Fos protein expression
Lena Wischhof et al.
PSYCHOPHARMACOLOGY (2012)
Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex
Cedric M. Hysek et al.
PSYCHOPHARMACOLOGY (2012)
NMDA Receptor and Schizophrenia: A Brief History
Joseph T. Coyle
SCHIZOPHRENIA BULLETIN (2012)
Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor
Michiko Fujimoto et al.
SYNAPSE (2012)
Toll-like receptor (TLR) and inflammasome actions in the central nervous system
Richa Hanamsagar et al.
TRENDS IN IMMUNOLOGY (2012)
The sigma-1 receptor: roles in neuronal plasticity and disease
Said Kourrich et al.
TRENDS IN NEUROSCIENCES (2012)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
Alkomiet Hasan et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2012)
Hypotheses relating to the function of the claustrum
John Smythies et al.
FRONTIERS IN INTEGRATIVE NEUROSCIENCE (2012)
The drugs don't work? antidepressants and the current and future pharmacological management of depression
Elizabeth Penn et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2012)
Hypotheses Regarding the Mechanisms of Ayahuasca in the Treatment of Addictions
Mitchell B. Liester et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2012)
Effects of the α2-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy Volunteers
Cedric M. Hysek et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
The Serotonin Transporter Promoter Variant (5-HTTLPR), Stress, and Depression Meta-analysis Revisited Evidence of Genetic Moderation
Katja Karg et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Charles S. Grob et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Differential effects of inescapable stress on locus coeruleus GRK3, alpha2-adrenoceptor and CRF1 receptor levels in learned helpless and non-helpless rats: A potential link to stress resilience
Manish Taneja et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Default-Mode and Task-Positive Network Activity in Major Depressive Disorder: Implications for Adaptive and Maladaptive Rumination
J. Paul Hamilton et al.
BIOLOGICAL PSYCHIATRY (2011)
Harnessing neuroplasticity for clinical applications
Steven C. Cramer et al.
BRAIN (2011)
Sex Differences in 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy)-Induced Cytochrome P450 2D6 Inhibition in Humans
Samanta Yubero-Lahoz et al.
CLINICAL PHARMACOKINETICS (2011)
The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (Ecstasy) in Humans
C. M. Hysek et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Effects of MDMA on Extracellular Dopamine and Serotonin Levels in Mice Lacking Dopamine and/or Serotonin Transporters
Y. Hagino et al.
CURRENT NEUROPHARMACOLOGY (2011)
5-HT and the immune system
Gerard P. Ahern
CURRENT OPINION IN PHARMACOLOGY (2011)
The role of serotonin receptors in the action of atypical antipsychotic drugs
H. Y. Meltzer et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
The size and burden of mental disorders and other disorders of the brain in Europe 2010
H. U. Wittchen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour
Maria Juliana Orejarena et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2011)
Sex Differences in the Effects of MDMA (Ecstasy) on Plasma Copeptin in Healthy Subjects
Linda D. Simmler et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Epigenetic modification of hippocampal Bdnf DNA in adult rats in an animal model of post-traumatic stress disorder
Tania L. Roth et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2011)
Structural brain abnormalities common to posttraumatic stress disorder and depression
Marijn C. W. Kroes et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2011)
The safety and efficacy of ± 3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study
Michael C. Mithoefer et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies
Erich Studerus et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor
C. Anacker et al.
MOLECULAR PSYCHIATRY (2011)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA
Noelia Granado et al.
NEUROBIOLOGY OF DISEASE (2011)
Stressor-induced NMDAR dysfunction as a unifying hypothesis for the aetiology, pathogenesis and comorbidity of clinical depression
W. N. Marsden
MEDICAL HYPOTHESES (2011)
An animal model of schizophrenia based on chronic LSD administration: Old idea, new results
Danuta Marona-Lewicka et al.
NEUROPHARMACOLOGY (2011)
Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors
Laura Albizu et al.
NEUROPHARMACOLOGY (2011)
Serotonin receptors and heart valve disease-It was meant 2B
Joshua D. Hutcheson et al.
PHARMACOLOGY & THERAPEUTICS (2011)
The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder
Courtney S. Jernigan et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Serum BDNF levels before treatment predict SSRI response in depression
Owen M. Wolkowitz et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Changes in brain anatomy during the course of posttraumatic stress disorder
Valerie A. Cardenas et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2011)
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Roland R. Griffiths et al.
PSYCHOPHARMACOLOGY (2011)
The Thalamic Reticular Nucleus and Schizophrenia
Fabio Ferrarelli et al.
SCHIZOPHRENIA BULLETIN (2011)
Serotonergic Projections and Serotonin Receptor Expression in the Reticular Nucleus of the Thalamus in the Rat
Jose J. Rodriguez et al.
SYNAPSE (2011)
The thalamic dynamic core theory of conscious experience
Lawrence M. Ward
CONSCIOUSNESS AND COGNITION (2011)
Genetic Sensitivity to the Environment: The Case of the Serotonin Transporter Gene and Its Implications for Studying Complex Diseases and Traits
Avshalom Caspi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Synapse regression in depression: the role of 5-HT receptors in modulating NMDA receptor function and synaptic plasticity
Maxwell R. Bennett
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2010)
Adult hippocampal neurogenesis and c-Fos induction during escalation of voluntary wheel running in C57BL/6J mice
Peter J. Clark et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Hetero-dimerization of serotonin 5-HT2A and dopamine D2 receptors
Sylwia Lukasiewicz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
Marije aan het Rot et al.
BIOLOGICAL PSYCHIATRY (2010)
A Meta-Analysis of Cytokines in Major Depression
Yekta Dowlati et al.
BIOLOGICAL PSYCHIATRY (2010)
Autonomic nervous system activity in emotion: A review
Sylvia D. Kreibig
BIOLOGICAL PSYCHOLOGY (2010)
Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?
Noreen T. Boyle et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Psychedelic 5-Methoxy-N,N-Dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions
Hong-Wu Shen et al.
CURRENT DRUG METABOLISM (2010)
Effects of a β-blocker on the cardiovascular response to MDMA (Ecstasy)
C. M. Hysek et al.
EMERGENCY MEDICINE JOURNAL (2010)
Role of serotonin and/or norepinephrine in the MDMA-induced increase in extracellular glucose and glycogenolysis in the rat brain
Rashida Pachmerhiwala et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial
Sanjay J. Mathew et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes
Juan E. Belforte et al.
NATURE NEUROSCIENCE (2010)
Thalamic synchrony and the adaptive gating of information flow to cortex
Qi Wang et al.
NATURE NEUROSCIENCE (2010)
OPINION The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Franz X. Vollenweider et al.
NATURE REVIEWS NEUROSCIENCE (2010)
CHRONIC FLUOXETINE TREATMENT INDUCES STRUCTURAL PLASTICITY AND SELECTIVE CHANGES IN GLUTAMATE RECEPTOR SUBUNITS IN THE RAT CEREBRAL CORTEX
E. Ampuero et al.
NEUROSCIENCE (2010)
THC Prevents MDMA Neurotoxicity in Mice
Clara Tourino et al.
PLOS ONE (2010)
Psychedelics and the Human Receptorome
Thomas S. Ray
PLOS ONE (2010)
Sigma receptors: Potential targets for a new class of antidepressant drug
James A. Fishback et al.
PHARMACOLOGY & THERAPEUTICS (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
A thalamic reticular networking model of consciousness
Byoung-Kyong Min
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2010)
Hyperphosphorylated tau in the brains of mice and monkeys with long-term administration of ketamine
L. Y. Yeung et al.
TOXICOLOGY LETTERS (2010)
Reduced Caudate and Nucleus Accumbens Response to Rewards in Unmedicated Individuals With Major Depressive Disorder
Diego A. Pizzagalli et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
Rebecca B. Price et al.
BIOLOGICAL PSYCHIATRY (2009)
Role of α1- and β3-adrenoceptors in the modulation by SR59230A of the effects of MDMA on body temperature in the mouse
Sotiria Bexis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Anti-amnesic properties of (±)-PPCC, a novel sigma receptor ligand, on cognitive dysfunction induced by selective cholinergic lesion in rats
Vuokko Antonini et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Vulnerability genes or plasticity genes?
J. Belsky et al.
MOLECULAR PSYCHIATRY (2009)
Predicting new molecular targets for known drugs
Michael J. Keiser et al.
NATURE (2009)
The locus coeruleus and noradrenergic modulation of cognition
Susan J. Sara
NATURE REVIEWS NEUROSCIENCE (2009)
Corticolimbic Transcriptome Changes are State-Dependent and Region-Specific in a Rodent Model of Depression and of Antidepressant Reversal
Alexandre Surget et al.
NEUROPSYCHOPHARMACOLOGY (2009)
ELEVATED 5-HT 2A RECEPTORS IN POSTMORTEM PREFRONTAL CORTEX IN MAJOR DEPRESSION IS ASSOCIATED WITH REDUCED ACTIVITY OF PROTEIN KINASE A
R. C. Shelton et al.
NEUROSCIENCE (2009)
The pharmacology of sigma-1 receptors
Tangui Maurice et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling
Kelly A. Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The default mode network and self-referential processes in depression
Yvette I. Sheline et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Brain-derived neurotrophic factor plasma levels in patients suffering from post-traumatic stress disorder
Liliana Dell'Osso et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
5-HT1A receptor function in major depressive disorder
Jonathan Savitz et al.
PROGRESS IN NEUROBIOLOGY (2009)
Resting state corticolimbic connectivity abnormalities in unmedicated bipolar disorder and unipolar depression
Amit Anand et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2009)
Oxytocin receptor polymorphisms and adult attachment style in patients with depression
Barbara Costa et al.
PSYCHONEUROENDOCRINOLOGY (2009)
Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI
Danuta Marona-Lewicka et al.
PSYCHOPHARMACOLOGY (2009)
Modeling psychosis in vitro by inducing disordered neuronal network activity in cortical brain slices
George K. Aghajanian
PSYCHOPHARMACOLOGY (2009)
The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator
Dominique Fontanilla et al.
SCIENCE (2009)
Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration
G. J. H. Dumont et al.
SOCIAL NEUROSCIENCE (2009)
Inhibition of NMDARs in the nucleus reticularis of the thalamus produces delta frequency bursting
Yuchun Zhang et al.
FRONTIERS IN NEURAL CIRCUITS (2009)
Gene-Environment Interaction in Posttraumatic Stress Disorder: An Update
Karestan C. Koenen et al.
JOURNAL OF TRAUMATIC STRESS (2009)
The association between dopamine D4 receptor exon III polymorphism and intensity of PTSD symptoms among flood survivors
Wojciech L. Dragan et al.
ANXIETY STRESS AND COPING (2009)
The brain's default network - Anatomy, function, and relevance to disease
Randy L. Buckner et al.
YEAR IN COGNITIVE NEUROSCIENCE 2008 (2008)
Cellular mechanisms underlying the antidepressant effects of ketamine:: Role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors
Sungho Maeng et al.
BIOLOGICAL PSYCHIATRY (2008)
Identification of N,N-dimethyltryptamine and beta-carbolines in psychotropic ayahuasca beverage
Cristiana Gambelunghe et al.
BIOMEDICAL CHROMATOGRAPHY (2008)
Extensive neuroadaptive changes in cortical gene-transcript expressions of the glutamate system in response to repeated intermittent MDMA administration in adolescent rats
Anna M. S. Kindlundh-Hogberg et al.
BMC NEUROSCIENCE (2008)
Adaptive properties and heterogeneity of dopamine D2 receptors -: Pharmacological implications
Arvid Carlsson et al.
BRAIN RESEARCH REVIEWS (2008)
The Self-Tuning Neuron: Synaptic Scaling of Excitatory Synapses
Gina G. Turrigiano
CELL (2008)
Serotonin receptors
David E. Nichols et al.
CHEMICAL REVIEWS (2008)
LSD-assisted psychotherapy in persons suffering from anxiety associated with advanced-stage life threatening diseases. A phase-II, double-blind, placebo-controlled dose-response pilot study
Torsten Passie et al.
CNS NEUROSCIENCE & THERAPEUTICS (2008)
The role of corticotropin-releasing factor and noradrenaline in stress-related responses, and the inter-relationships between the two systems
Adrian J. Dunn et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
5-Hydroxytryptamine (5HT)-induced valvulopathy: Compositional. valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats
Chandikumar S. Elangbam et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2008)
The Role of AMPA receptor modulation in the treatment of neuropsychiatric diseases
Carlos A. Zarate et al.
EXPERIMENTAL NEUROLOGY (2008)
AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression
S. Chourbaji et al.
FASEB JOURNAL (2008)
Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review
R. Maculaitis et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2008)
Metabotropic glutamate 5 receptors regulate sensitivity to ethanol in mice
Michael K. Bird et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions
Bruno P. Guiard et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
The consequences of 3.4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans
Brian O'Mathuna et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Projections of the paraventricular and paratenial nuclei of the dorsal midline thalamus in the rat
Robert P. Vertes et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2008)
Serotonin 5-Hydroxytryptamine2A Receptor Activation Suppresses Tumor Necrosis Factor-α-Induced Inflammation with Extraordinary Potency
Bangning Yu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor
Christopher D. Verrico et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
R. R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response
M-L Wong et al.
MOLECULAR PSYCHIATRY (2008)
Identification of a serotonin/glutamate receptor complex implicated in psychosis
Javier Gonzalez-Maeso et al.
NATURE (2008)
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Gerard Sanacora et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
From inflammation to sickness and depression: when the immune system subjugates the brain
Robert Dantzer et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Chronic treatment with a selective ligand for the sigma-1 receptor chaperone, SA4503, up-regulates BDNF protein levels in the rat hippocampus
Kazue Kikuchi-Utsumi et al.
NEUROSCIENCE LETTERS (2008)
Epigenetic and pharmacoepigenomic studies of major psychoses and potentials for therapeutics
Hamid Mostafavi Abdolmaleky et al.
PHARMACOGENOMICS (2008)
Marked decrease of LSD-induced stimulus control in serotonin transporter knockout mice
C. M. Krall et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Agonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivo
Cullen L. Schmid et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Reduced efficacy of fluoxetine following MDMA (Ecstasy)-induced serotonin loss in rats
Sarah Durkin et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
The link between childhood trauma and depression: Insights from HPA axis studies in humans
Christine Heim et al.
PSYCHONEUROENDOCRINOLOGY (2008)
Consciousness and Anesthesia
Michael T. Alkire et al.
SCIENCE (2008)
The HPA axis in major depression: classical theories and new developments
Carmine M. Pariante et al.
TRENDS IN NEUROSCIENCES (2008)
Serotonin research: contributions to understanding psychoses
Mark A. Geyer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders - First Revision
Borwin Bandelow et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2008)
Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers
Manel J. Barbanoj et al.
PSYCHOPHARMACOLOGY (2008)
Stress, depression, and neuroplasticity: A convergence of mechanisms
Christopher Pittenger et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Interaction between BDNF and serotonin: Role in mood disorders
Keri Martinowich et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase
M. Margarita Behrens et al.
SCIENCE (2007)
Long-term down-regulation of BDNF mRNA in rat hippocampal CA1 subregion correlates with PTSD-like behavioural stress response
Nitsan Kozlovsky et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Sigma-1 receptor chaperones at the ER-Mitochondrion interface regulate Ca2+ signaling and cell survival
Teruo Hayashi et al.
CELL (2007)
NMDA receptor hypofunction produces opposite effects on prefrontal cortex Interneurons and pyramidal neurons
Houman Homayoun et al.
JOURNAL OF NEUROSCIENCE (2007)
High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine:: A positron emission tomography study using [11C]SA4503
Masatomo Ishikawa et al.
BIOLOGICAL PSYCHIATRY (2007)
Psilocybin-induced stimulus control in the rat
J. C. Winter et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine
Lucila Kargieman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval
Franz X. Vollenweider et al.
NEUROPSYCHOPHARMACOLOGY (2007)
New insights into BDNF function in depression and anxiety
Keri Martinowich et al.
NATURE NEUROSCIENCE (2007)
A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis
Michael A. Benneyworth et al.
MOLECULAR PHARMACOLOGY (2007)
Dopamine and serotonin receptor binding and antipsychotic efficacy
Neil M. Richtand et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Decreased plasma BDNF level in depressive patients
Bun-Hee Lee et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex
Jean-Claude Beique et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Combined immunomodulating properties of 3,4-methylenedioxymethamphetamine (MDMA) and cannabis in humans
Roberta Pacifici et al.
ADDICTION (2007)
Traumatic life events in bipolar disorder: impact on BDNF levels and psychopathology
Marcia Kauer-Sant'Anna et al.
BIPOLAR DISORDERS (2007)
A role for oxytocin and 5-HT1A receptors in the prosocial effects of 3,4-methylenedioxymethamphetamine (ecstasy)
M. R. Thompson et al.
NEUROSCIENCE (2007)
Epigenetic regulation in psychiatric disorders
Nadia Tsankova et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Brain-derived neurotrophic factor regulates the expression and synaptic delivery of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunits in hippocampal neurons
Margarida V. Caldeira et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Caspase 1 deficiency reduces inflammation-induced brain transcription
Claudio Mastronardi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The α1b-adrenoceptor exists as a higher-order oligomer:: Effective oligomerization is required for receptor maturation, surface delivery, and function
Juan F. Lopez-Gimenez et al.
MOLECULAR PHARMACOLOGY (2007)
The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain
Fumiko Nagai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography
Maria A. Oquendo et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior
Javier Gonzalez-Maeso et al.
NEURON (2007)
Low plasma BDNF is associated with suicidal behavior in major depression
Yong-Ku Kim et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings
Michael H. Baumann et al.
PSYCHOPHARMACOLOGY (2007)
Functional selectivity and classical concepts of quantitative pharmacology
Jonathan D. Urban et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Molecular mechanisms of memory reconsolidation
Natalie C. Tronson et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Interactions between 3,4-methylenedioxymethamphetamine and σ1 receptors
Matthew K. Brammer et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Efferent projections of reuniens and rhomboid nuclei of the thalamus in the rat
Robert P. Vertes et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2006)
Comorbidity was associated with neurologic and psychiatric diseases: A general practice-based controlled study
Jasper Nuyen et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2006)
The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats
Kirsten Krebs-Thomson et al.
PSYCHOPHARMACOLOGY (2006)
Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice
Victoria B. Risbrough et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder
Francisco A. Moreno et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Clozapine and olanzapine, but not haloperidol, suppress serotonin efflux in the medial prefrontal cortex elicited by phencyclidine and ketamine
Merce Amargos-Bosch et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2006)
1-aminomethylbenzocycloalkanes:: Conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists
Thomas H. McLean et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Relationship between posttrauma GABA plasma levels and PTSD at 1-year follow-up
Guillaume Vaiva et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Hallucinogen-induced UP states in the brain slice of rat-prefrontal cortex: Role of glutamate spillover and NR2B-NMDA receptors
Evelyn K. Lambe et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
R. R. Griffiths et al.
PSYCHOPHARMACOLOGY (2006)
Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release
Y Yagasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant
J Riba et al.
PSYCHOPHARMACOLOGY (2006)
Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder
XZ Hu et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Attentional modulation of thalamic reticular neurons
K McAlonan et al.
JOURNAL OF NEUROSCIENCE (2006)
The norepinephrine transporter and its regulation
P Mandela et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Mechanism of action of memantine
JW Johnson et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors
M Yamauchi et al.
BRAIN RESEARCH (2006)
Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management
AP Hall et al.
BRITISH JOURNAL OF ANAESTHESIA (2006)
Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients
Aitor Palomino et al.
SCHIZOPHRENIA RESEARCH (2006)
Cytokines sing the blues: inflammation and the pathogenesis of depression
CL Raison et al.
TRENDS IN IMMUNOLOGY (2006)
The neuroplasticity-associated Arc gene is a direct transcriptional target of early growth response (Egr) transcription factors
L Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity:: Role in atypical antipsychotic action
L Díaz-Mataix et al.
JOURNAL OF NEUROSCIENCE (2005)
Ketamine impairs excitability in superficial dorsal horn neurones by blocking sodium and voltage-gated potassium currents
R Schnoebel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression
PV Choudary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Psychological and cognitive effects of long-term peyote use among Native Americans
JH Halpern et al.
BIOLOGICAL PSYCHIATRY (2005)
The 5-HT1A receptor and the stimulus effects of LSD in the rat
CJ Reissig et al.
PSYCHOPHARMACOLOGY (2005)
Th1, Th2, and Th3 cytokine alterations in major depression
AM Myint et al.
JOURNAL OF AFFECTIVE DISORDERS (2005)
Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors
OL Carter et al.
JOURNAL OF COGNITIVE NEUROSCIENCE (2005)
Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex
PJ Gresch et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states:: Focus on novel therapeutic strategies
MJ Millan
THERAPIE (2005)
Mental disorders in current and former heavy ecstasy (MDMA) users
R Thomasius et al.
ADDICTION (2005)
Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics
P Seeman et al.
MOLECULAR PSYCHIATRY (2005)
Role of α2A-adrenoceptors in the effects of MDMA on body temperature in the mouse
S Bexis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
High-affinity binding of, β-carbolines to imidazoline I2B receptors and MAO-A in rat tissues:: Norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain
A Miralles et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: Comparison with antidepressant drugs
G Gobbi et al.
PEPTIDES (2005)
Distinct temporal phases in the behavioral pharmacology of LSD:: dopamine D2 receptor-mediated effects in the rat and implications for psychosis
D Marona-Lewicka et al.
PSYCHOPHARMACOLOGY (2005)
What is the function of the claustrum?
FC Crick et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2005)
5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression
L Pezawas et al.
NATURE NEUROSCIENCE (2005)
Ayahuasca in adolescence: A preliminary psychiatric assessment
DX Da Silveira et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2005)
Long-term serotonin administration induces heart valve disease in rats
BI Gustafsson et al.
CIRCULATION (2005)
The serotonin syndrome
EW Boyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
An integrative theory of locus coeruleus-norepinephrine function: Adaptive gain and optimal performance
G Aston-Jones et al.
ANNUAL REVIEW OF NEUROSCIENCE (2005)
The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study
O Aydemir et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder
HJ Lee et al.
DEPRESSION AND ANXIETY (2005)
Blood-brain barrier transport of cytokines: A mechanism for neuropathology
WA Banks
CURRENT PHARMACEUTICAL DESIGN (2005)
AMPA receptor potentiators as novel antidepressants
A Alt et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Mood disorders and serotonin transporter density in ecstasy users - the influence of long-term abstention, dose, and gender
MML de Win et al.
PSYCHOPHARMACOLOGY (2004)
MDMA (Ecstasy) controls in concert a group of genes involved in GABA neurotransmission
R Simantov et al.
FEBS LETTERS (2004)
Hypocortisolism and increased glucocorticoid sensitivity of pro-inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder
N Rohleder et al.
BIOLOGICAL PSYCHIATRY (2004)
Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study
F Hasler et al.
PSYCHOPHARMACOLOGY (2004)
Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys
WE Fantegrossi et al.
BEHAVIOURAL PHARMACOLOGY (2004)
Corticothalamic inhibition in the thalamic reticular nucleus
LM Zhang et al.
JOURNAL OF NEUROPHYSIOLOGY (2004)
Claviceps purpurea:: molecular aspects of a unique pathogenic lifestyle
P Tudzynski et al.
MOLECULAR PLANT PATHOLOGY (2004)
Molecular genetic responses to lysergic acid diethylamide include transcriptional activation of MAP kinase phosphatase-1, C/EBP-β and ILAD-1, a novel gene with homology to arrestins
CD Nichols et al.
JOURNAL OF NEUROCHEMISTRY (2004)
The neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine on serotonin, dopamine, and GABA-ergic terminals: An in-vitro autoradiographic study in rats
BD Armstrong et al.
NEUROTOXICOLOGY (2004)
Stereoselective effects of ketamine on dopamine, serotonin and noradrenaline release and uptake in rat brain slices
MM Tso et al.
NEUROCHEMISTRY INTERNATIONAL (2004)
Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with α1- plus β3-adrenoreceptor antagonists
JE Sprague et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Beneficial effects of the sigma, receptor agonists igmesine and dehydroepiandrosterone against learning impairments in rats prenatally exposed to cocaine
J Meunier et al.
NEUROTOXICOLOGY AND TERATOLOGY (2004)
Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release
MG Bankson et al.
JOURNAL OF NEUROCHEMISTRY (2004)
NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex
ME Jackson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
AMPA Receptor Potentiators for the Treatment of CNS Disorders
Michael J. O'Neill et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2004)
Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex
JW Muschamp et al.
BRAIN RESEARCH (2004)
Modulating Th1/Th2 responses with microbes, dendritic cells, and pathogen recognition receptors
B Pulendran
IMMUNOLOGIC RESEARCH (2004)
Psychiatric comorbidity in a population of Parkinson's disease patients
A Nuti et al.
EUROPEAN JOURNAL OF NEUROLOGY (2004)
Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls
E Shimizu et al.
NEUROSCIENCE LETTERS (2003)
Pharmacological characterization of a serotonin receptor (5-HT7) stimulating cAMP production in human corneal epithelial cells
JY Crider et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Anesthetics inhibit high-affinity states of dopamine D2 and other G-linked receptors
P Seeman et al.
SYNAPSE (2003)
Animal behavior models of the mechanisms underlying antipsychotic atypicality
MA Geyer et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)
AR Green et al.
PHARMACOLOGICAL REVIEWS (2003)
The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats
JL Scruggs et al.
NEUROSCIENCE LETTERS (2003)
In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors:: Relationship to thalamocortical afferents
MV Puig et al.
CEREBRAL CORTEX (2003)
Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene
A Caspi et al.
SCIENCE (2003)
Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants
E Shimizu et al.
BIOLOGICAL PSYCHIATRY (2003)
Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics
J Riba et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
MDMA (ecstasy) and neurotoxicity
M Mithoefer et al.
SCIENCE (2003)
Molecular correlates of impaired prefrontal plasticity in response to chronic stress
SD Kuipers et al.
JOURNAL OF NEUROCHEMISTRY (2003)
The corticothalamic system in sleep
M Steriade
FRONTIERS IN BIOSCIENCE-LANDMARK (2003)
Altered gene expression in frontal cortex and midbrain of 3,4-methylenedioxymethamphetamine (MDMA) treated mice: Differential regulation of GABA transporter subtypes
WP Peng et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
IL-10 mediates sigma1 receptor-dependent suppression of antitumor immunity
LX Zhu et al.
JOURNAL OF IMMUNOLOGY (2003)
Altered states: the clinical effects of ecstasy
JC Cole et al.
PHARMACOLOGY & THERAPEUTICS (2003)
Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features
AG Lerner et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2003)
Serotonin syndrome and other serotonergic disorders
RA Ener et al.
PAIN MEDICINE (2003)
Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects
WE Evans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Course of illness, hippocampal function, and hippocampal volume in major depression
GM MacQueen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm
JH Meyer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone
Y Yamanouchi et al.
PHARMACOGENOMICS JOURNAL (2003)
Effects of antidepressants on the production of cytokines
G Kenis et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2002)
Ketamine does not decrease striatal dopamine D2 receptor binding in man
S Aalto et al.
PSYCHOPHARMACOLOGY (2002)
Determination of N,N-dimethyltryptamine and β-carboline alkaloids in human plasma following oral administration of Ayahuasca
M Yritia et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)
The pharmacology of psilocybin
T Passie et al.
ADDICTION BIOLOGY (2002)
Severe Dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA (ecstasy)
GA Ricaurte et al.
SCIENCE (2002)
Analgesic effect of intrathecally administered orexin-A in the rat formalin test in the rat hot plate test
T Yamamoto et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Antidepressants and neuroplasticity
C D'Sa et al.
BIPOLAR DISORDERS (2002)
Up-regulation of noradrenaline transporter in response to prolonged exposure to ketamine
K Hara et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2002)
Acute psychological and neurophysiological effects of MDMA in humans
FX Vollenweider et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2002)
Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors
G Sanacora et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity
AC Parrott
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D-2 and serotonin 5-HT2 receptors - implications for models of schizophrenia
S Kapur et al.
MOLECULAR PSYCHIATRY (2002)
The acute and chronic effects of MDMA (Ecstasy) on cortical 5-HT2A receptors in rat and human brain
L Reneman et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [I-123]beta-CIT SPECT study - preliminary report
L Reneman et al.
PSYCHOPHARMACOLOGY (2002)
Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide
MC Austin et al.
NEUROSCIENCE (2002)
The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats
AO Mechan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
NMDA antagonist effects on striatal dopamine release: Positron emission tomography studies in humans
LS Kegeles et al.
SYNAPSE (2002)
Ketamine alters the availability of striatal dopamine transporter as measured by [11C]β-CFT and [11C]β-CIT-FE in the monkey brain
H Tsukada et al.
SYNAPSE (2001)
Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism
R Martín-Ruiz et al.
JOURNAL OF NEUROSCIENCE (2001)
Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor
JR Bunzow et al.
MOLECULAR PHARMACOLOGY (2001)
Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach
L Reneman et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2001)
Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research
AC Parrott
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2001)
Paradoxical trafficking and regulation of 5HT2A receptors by agonists and antagonists
JA Gray et al.
BRAIN RESEARCH BULLETIN (2001)
Dendritic cell subsets and the regulation of Th1/Th2 responses
R Maldonado-López et al.
SEMINARS IN IMMUNOLOGY (2001)
The thalamic matrix and thalamocortical synchrony
EG Jones
TRENDS IN NEUROSCIENCES (2001)
Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats
A Mayerhofer et al.
NEUROSCIENCE LETTERS (2001)
5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells
LD Van de Kar et al.
JOURNAL OF NEUROSCIENCE (2001)
Gender differences in the subjective effects of MDMA
ME Liechti et al.
PSYCHOPHARMACOLOGY (2001)
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
JE Malberg et al.
JOURNAL OF NEUROSCIENCE (2000)
Dual effects of intravenous anesthetics on the function of norepinephrine transporters
K Hara et al.
ANESTHESIOLOGY (2000)
Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors
JC Gewirtz et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Recreational use of Aminorex and pulmonary hypertension
SP Gaine et al.
CHEST (2000)
Ketamine blockage of both tetrodotoxin (TTX)-sensitive and TTX-resistant sodium channels of rat dorsal root ganglion neurons
ZS Zhou et al.
BRAIN RESEARCH BULLETIN (2000)
Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder
JD Bremner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Subunit-dependent inhibition of human neuronal nicotinic acetylcholine receptors and other ligand-gated ion channels by dissociative anesthetics ketamine and dizocilpine
T Yamakura et al.
ANESTHESIOLOGY (2000)
Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) are attenuated by the serotonin uptake inhibitor citalopram
ME Liechti et al.
NEUROPSYCHOPHARMACOLOGY (2000)
An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats
TJ Connor et al.
IMMUNOPHARMACOLOGY (2000)
Intravenous anesthetics differentially modulate ligand-gated ion channels
P Flood et al.
ANESTHESIOLOGY (2000)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin-releasing hormone
ML Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Effects of (S)-ketamine on striatal dopamine: a [C-11]raclopride PET study of a model psychosis in humans
FX Vollenweider et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2000)
分享论文
